News
As restrictions tighten on compounded semaglutide, FuturHealth now offers name-brand GLP-1s-like Wegovy®- through Novo's cash-pay program S ...
Stockhead on MSN20m
Doubling up: How ASX biotechs are multiplying their impact
ASX companies such as LTR Pharma are finding smarter ways to stretch the value of existing assets and launch into ... Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback